After a high-profile fight between the manufacturer of the EpiPen and Congress over a spike in price for the anti-allergy drug injectors, U.S. Rep. Rosa DeLauro is calling for more oversight of the cost of prescription drugs and medical devices.
DeLauro plans to introduce legislation to create a price review board that would collect data on drug prices and manufacturing costs and couldimpose fines if prices are deemed excessive.
"Not all companies have engaged in this predatory practice, but we do have some," said the 3rd District representative. "We have to hold the bad actors accountable."
The Drug and Device Price Review Board Act of 2016, which...